January 2026
The global at-home peptic ulcer testing market size was evaluated at USD 322.15 million in 2025 and is predicted to hit around USD 575.83 million by 2035, growing at a CAGR of 5.98%.
September 2026
The global pharmaceutical analytical testing market size is expected to hit around USD 22.60 billion by 2035 from USD 10.76 billion in 2026 , with a CAGR of 8.62%.
September 2026
The global enzyme-linked immunosorbent assay testing market size is estimated to hit around USD 4.41 billion by 2035 increasing from USD 2.57 billion in 2026, with a CAGR of 6.18%.
September 2026
The global preterm birth and PROM testing market size is projected to hit around USD 3.45 billion by 2034 from USD 1.82 billion in 2026 with a CAGR of 8.22%.
September 2026
The global drug of abuse testing market size was estimated at USD 15.42 billion in 2026 and is projected to hit around USD 24.14 billion by 2035, with a notable CAGR of 5.11%.
September 2026
The point of care testing market size is expected to increase from USD 49.90 billion in 2026 and is projected to hit around USD 125.33 billion by 2034 with a CAGR of 12.20%.
September 2026
The direct-to-consumer laboratory testing market size is projected to hit around USD 8.69 billion by 2035 from USD 4.08 billion in 2026 with a CAGR of 8.77%.
September 2026
The global healthcare analytical testing services market size is estimated at USD 18.54 billion in 2026 and is expected to hit around USD 38.09 billion by 2035, growing a CAGR of 8.34% from 2026 to 2035.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
September 2026
The global pharmaceutical rapid microbiology testing market size is estimated to hit around USD 6.40 billion by 2035 from USD 1.32 billion in 2025, with a CAGR of 17.10%.
September 2026
The global genetic toxicology testing market size was evaluated at USD 2.49 billion in 2026 and is predicted to hit around USD 5.97 billion by 2035, growing at a CAGR of 10.20%.
September 2026
The global EMC testing market size was evaluated at USD 3.42 billion in 2026 and is predicted to hit around USD 6.62 billion by 2035, growing at a CAGR of 7.60%.
September 2026
The global venous leg ulcer market size is estimated to hit around USD 8.47 billion by 2034 increasing from USD 2.25 billion in 2024, with a CAGR of 14.18%.
September 2026
The global pyrogen testing market size was evaluated at USD 1.89 billion in 2026 and is predicted to hit around USD 4.50 billion by 2035, growing at a CAGR of 10.10%.
September 2026
The c reactive protein testing market size stood at USD 5.59 billion in 2026, with major c reactive protein testing market companies including Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Danaher, Quest Diagnostics, Siemens Healthineers AG, Abbott.
September 2026
The global enteric disease testing market size was evaluated at USD 4.58 billion in 2026 and is predicted to hit around USD 8.09 billion by 2035, growing at a CAGR of 6.52%.
September 2026
The nanomechanical testing market was worth USD 1.19 billion in 2026, with key nanomechanical testing market players including Anton Paar GmbH, Hysitron (now part of Bruker Corporation), Keysight Technologies Inc., Oxford Instruments PLC.
September 2026
The metabolic testing equipment market was valued at USD 2.07 billion in 2026, with leading companies including Cardiometabolic Health Solutions, Inc., Vyaire Medical Inc., Cosmed S.r.l., Schiller AG.
September 2026
The U.S. diabetic foot ulcer treatment market generated USD 3.87 billion in 2026, with prominent U.S. diabetic foot ulcer treatment market companies including 3M / Solventum, Smith+Nephew, Mölnlycke Health Care.
September 2026
The cardiac marker testing market reached USD 6.01 billion in 2026, featuring leading cardiac marker testing market companies such as Abbott Laboratories, Alere Inc., bioMérieux SA.
September 2026
The global food safety testing market size is estimated at USD 28.99 billion in 2026 and is predicted to hit around USD 55.05 billion by 2035 with a CAGR of 7.42%.
September 2026
The global container closure integrity testing service market size is estimated to hit around USD 3.34 billion by 2034 increasing from USD 1.64 billion in 2026 , with a CAGR of 9.32%.
September 2026
The hydrogen technology testing, inspection, and certification market size is projected to hit around USD 29.93 billion by 2035 from USD 5.41 billion in 2025, with a CAGR of 18.23%.
September 2026
The US direct-to-consumer laboratory testing market size was evaluated at USD 1.34 billion in 2026 and is predicted to hit around USD 2.92 billion by 2035, growing at a CAGR of 9.03%.
September 2026
The rapid microbiology testing market size was USD 4.07 billion in 2026, with leading rapid microbiology testing market players including Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc.
September 2026
The non-invasive prenatal testing market size was USD 8.05 billion in 2026, with leading non-invasive prenatal testing market players including Genesis Genetics, Natera, Centogene, Eurofins LifeCodexx GmbH.
September 2026
The rapid microbiology testing market size was USD 7.37 billion in 2026, with leading rapid microbiology testing market players including Creative Diagnostics, bioMérieux, Synbiosis, Thermo Fisher Scientific,
August 2026
The direct-to-consumer genetic testing market reached USD 2.45 billion in 2026, featuring leading direct-to-consumer genetic testing companies such as Identigene, Karmagenes, Living DNA, Mapmygenome.
August 2026
Deepa Pandey a Healthcare Industry Expert, highlights that the bioanalytical testing services market has reached USD USD 6.23 billion in 2026 and is on track to reach USD 13.59 billion by 2035, advancing at a CAGR of 9.08%. Key bioanalytical testing services market companies shaping the market include PPD, Inc., ICON Plc, Charles River Laboratories International, Covance, Inc. while major growth segments By Test Type, By Molecules, By Application, By End User, By Region.
August 2026
The global hemoglobin testing market size is calculated at USD 3.04 billion in 2025 and is projected to hit around USD 6.02 billion by 2035 with a CAGR of 7.07%.